Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

Published:2011-10-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sharma Pawana¹,Blackburn Rachel C²,Parke Claire L²,McCullough Keith²,Marks Angharad²,Black Corri²

Affiliation:

1. University of Aberdeen; Health Services Research Unit; Foresterhill Aberdeen Grampian UK AB25 2ZD

2. University of Aberdeen; Institute of Applied Health Sciences; Foresterhill Aberdeen Grampian UK AB52 6NZ

Publisher

Wiley

Subject

Pharmacology (medical)

Reference160 articles.

1. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group;Locatelli;Kidney International - Supplement,1997

2. Maschio G Alberti D Janin G Locatelli F Mann J Motolese M The use of benazepril in the treatment of progressive renal disease [abstract] 13th International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 65

3. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group;Maschio;New England Journal of Medicine,1996

4. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group;Maschio;Journal of Cardiovascular Pharmacology,1999

5. Differing anti-proteinuric action of candesartan and losartan in chronic renal disease;Matsuda;Hypertension Research: Official Journal of the Japanese Society of Hypertension,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying the benefits of increasing decision-making frequency for health applications with regular decision epochs;IISE Transactions;2024-04-10

2. A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension;Nephrology Dialysis Transplantation;2024-02-14

3. Use of ACEi/ARBs, SGLT2 inhibitors and MRAs can help us reach the therapeutic ceiling in CKD;Clinical Kidney Journal;2024-01-31

4. Association between Neck Circumference and Chronic Kidney Disease in Korean Adults in the 2019–2021 Korea National Health and Nutrition Examination Survey;Nutrients;2023-12-08

5. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26